2017
DOI: 10.1016/j.hfc.2017.02.013
|View full text |Cite
|
Sign up to set email alerts
|

Left Ventricular Assist Device in Older Adults

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 50 publications
0
4
0
Order By: Relevance
“…Usually, intervention with ablation must be performed in centers with experience. Intravenous amiodarone and sodium channel-blocking agents such as procainamide remain the preferred drug regimen in the short-term setting [ 65 ]. The usual source of ventricular arrhythmias is the surrounding area of the inflow cannula.…”
Section: Complicationsmentioning
confidence: 99%
“…Usually, intervention with ablation must be performed in centers with experience. Intravenous amiodarone and sodium channel-blocking agents such as procainamide remain the preferred drug regimen in the short-term setting [ 65 ]. The usual source of ventricular arrhythmias is the surrounding area of the inflow cannula.…”
Section: Complicationsmentioning
confidence: 99%
“…Long-term assistance is only used as a transition in heart transplantation, and this should be used with caution in patients with advanced age. 82…”
Section: Drug Therapy For Elderly Patients With Hfpefmentioning
confidence: 99%
“…Use of a left ventricular assist device has become a common treatment for advanced HF. Long‐term assistance is only used as a transition in heart transplantation, and this should be used with caution in patients with advanced age 82 …”
Section: Treatment and Comprehensive Managementmentioning
confidence: 99%
“…Particular to the heart transplants and due to the scarcity of organs overall, in older adults, end-stage-heart-disease has led to more destination left ventricular assist devices (VADs) which can provide a good alternative to transplant, with manageable symptoms yet without the risks of immunosuppression. VADs have also been associated with a risk of infection[ 45 ] and an increase in suppressive T-regulatory cells[ 46 ]. Overall, the distribution of adults on the waitlist has shifted to more patients being transplanted from VAD support[ 36 ], despite evidence that older patients have worse outcomes, and higher risk of stroke and gastrointestinal bleeding with VAD therapy[ 47 ].…”
Section: Organ Specific Considerations In Older Recipients Peri- and Post-transplant Periodmentioning
confidence: 99%